  Autism Spectrum Disorder is one of the leading neurodevelopmental disorders
in our world, present in over 1% of the population and rapidly increasing in
prevalence, yet the condition lacks a robust, objective, and efficient
diagnostic. Clinical diagnostic criteria rely on subjective behavioral
assessments, which are prone to misdiagnosis as they face limitations in terms
of their heterogeneity, specificity, and biases. This study proposes a novel
convolutional-neural-network based classification tool that aims to identify
the potential of different neuroimaging features as autism biomarkers. The
model is constructed using a set of sequential layers specifically designed to
extract relevant features from brain scans. Trained and tested on over 300,000
distinct features across three imaging types, the model shows promising
results, achieving an accuracy of 95.4% and outperforming metrics of current
gold standard diagnostics. 32 optimal features from the imaging data were
identified and classified as candidate biomarkers using an independent samples
t-test, in which functional features such as neural activity and connectivity
in various brain regions exhibited the highest differences in the mean values
between individuals with autism and typical control subjects. The p-values of
these biomarkers were < 0.001, proving the statistical significance of the
results and indicating that this research could pave the way towards the usage
of neuroimaging in conjunction with behavioral criteria in clinics.
Furthermore, the salient features discovered in the brain structure of
individuals with autism could lead to a more profound understanding of the
underlying neurobiological mechanisms of the disorder, which remains one of the
most substantial enigmas in the field even today.
